Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : DNDI-6174
Catalog No.: PC-21550Not For Human Use, Lab Use Only.
DNDI-6174 is a highly potent inhibitor of Leishmania cytochrome bc1 complex activity, shows broad activity against a panel of representative visceral leishmaniasis clinical isolates from various sources (EC50=10-360 nM).
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
DNDI-6174 is a highly potent inhibitor of Leishmania cytochrome bc1 complex activity, shows broad activity against a panel of representative visceral leishmaniasis clinical isolates from various sources (EC50=10-360 nM).
DNDI-6174 is active against clones resistant to currently used therapeutics, such as paromomycin (PM) and miltefosine (MIL).
DNDI-6174 shows high potency against T. cruzi (Tulahuen strain, EC50 value of <5 nM), the causative agent of Chagas disease, considerably less active against T. brucei brucei and T. brucei rhodesiense (bloodstream form) associated with human African trypanosomiasis, with EC50 values ranging from 5 to 20 μM.
DNDI-6174 targets the Qi site of L donovani cytochrome b.
DNDI-6174 is a potent inhibitor of complex III in lysates prepared from both promastigote and axenic amastigote stages of L. donovani with IC50 of 8 nM and 2 nM respectively.
DNDI-6174 shows potent in vitro antileishmanial activity against a range of Leishmania species responsible for causing VL or CL and current drug-resistant species and clinical isolates.
DNDI-6174 (12.5 mg/kg twice daily or 25 mg/kg once daily) decreased the liver parasite burden of infected BALB/c mice.
| M.Wt | 307.31 | |
| Formula | C16H13N5O2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Stéphanie Braillard, et al. Sci Transl Med. 2023 Dec 13;15(726):eadh9902.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
